DiGeorge Syndrome

DiGeorge Syndrome (22q11.2 Deletion Syndrome)

DiGeorge Syndrome is a primary immunodeficiency disorder characterized by:

  • Thymic hypoplasia or aplasia
  • Parathyroid hypoplasia
  • Congenital heart defects
  • Characteristic facial features
  • Developmental delays

Incidence: Approximately 1:4000 live births, making it the most common microdeletion syndrome in humans.

Key Clinical Manifestations

Cardiac Abnormalities (75-80%):

  • Conotruncal Defects
    • Tetralogy of Fallot
    • Interrupted aortic arch type B
    • Truncus arteriosus
    • Vascular rings
    • VSD with aortic arch anomalies

Immunologic Features:

  • T-Cell Abnormalities
    • Variable T-cell deficiency
    • Thymic hypoplasia/aplasia
    • Recurrent infections
    • Autoimmune disorders
  • Clinical Presentations
    • Recurrent sinopulmonary infections
    • Candidiasis
    • Viral infections
    • Autoimmune cytopenias

Endocrine Manifestations:

  • Hypocalcemia
    • Neonatal tetany
    • Seizures
    • Parathyroid hypoplasia
  • Other Endocrine Issues
    • Growth hormone deficiency
    • Thyroid dysfunction
    • Obesity

Craniofacial Features:

  • Hypertelorism
  • Short palpebral fissures
  • Bulbous nasal tip
  • Small mouth
  • Micrognathia
  • Low-set, dysplastic ears
  • Cleft palate/velopharyngeal insufficiency

Developmental Features:

  • Neurodevelopmental Issues
    • Speech and language delays
    • Learning difficulties
    • Motor delays
    • Behavioral problems
    • Autism spectrum features

Diagnostic Approach

Genetic Testing:

  • Primary Tests
    • FISH analysis for 22q11.2 deletion
    • Microarray analysis
    • Next-generation sequencing
  • Family Testing
    • Parental testing
    • Sibling screening
    • Genetic counseling

Immunologic Evaluation:

  • T-Cell Studies
    • Complete blood count
    • Lymphocyte subsets
    • T-cell proliferation studies
    • Thymic imaging
  • Antibody Studies
    • Immunoglobulin levels
    • Vaccine responses
    • Autoantibody screening

Cardiac Evaluation:

  • Echocardiogram
  • Cardiac MRI
  • CT angiography
  • Cardiac catheterization if needed

Additional Evaluations:

  • Calcium studies
  • Parathyroid function tests
  • Developmental assessment
  • Speech evaluation
  • Feeding assessment

Treatment Strategies

Cardiac Management:

  • Surgical Intervention
    • Timing of cardiac surgery
    • Pre-operative optimization
    • Post-operative care
    • Long-term cardiac follow-up

Immunologic Care:

  • Infection Prevention
    • Prophylactic antibiotics
    • IVIG if indicated
    • Vaccination strategy
    • Live vaccine precautions
  • Autoimmune Management
    • Monitoring for autoimmune conditions
    • Immunosuppression if needed
    • Regular immunologic assessment

Endocrine Management:

  • Calcium Homeostasis
    • Calcium supplementation
    • Vitamin D therapy
    • Regular monitoring
    • Emergency management plans

Developmental Support:

  • Early Intervention
    • Speech therapy
    • Occupational therapy
    • Physical therapy
    • Educational support
  • Behavioral Support
    • Psychological assessment
    • Behavioral interventions
    • Social skills training

Genetics and Pathophysiology

Genetic Basis:

  • Deletion Characteristics
    • 22q11.2 deletion (3Mb typical)
    • TBX1 gene haploinsufficiency
    • Affects neural crest development
    • Multiple genes involved
  • Inheritance Pattern
    • Autosomal dominant
    • 90% de novo mutations
    • 10% inherited
    • Variable expressivity

Long-term Monitoring

Regular Assessments:

  • Annual Evaluations
    • Growth and development
    • Immunologic status
    • Cardiac function
    • Calcium levels
    • Educational progress
  • Specialty Care
    • Immunology follow-up
    • Cardiology monitoring
    • Endocrine assessment
    • Speech therapy review
    • Psychiatric evaluation

Transition Care:

  • Transition to adult care
  • Vocational training
  • Independent living skills
  • Family support services


Further Reading
Powered by Blogger.